| Debra Joan Kurtz, MD | |
|
1200 Sixth St, Ste 400, Traverse City, MI 49684-2369 | |
| (231) 392-0655 | |
| (231) 392-0665 |
| Full Name | Debra Joan Kurtz |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1200 Sixth St, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184674616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301051369 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra Joan Kurtz, MD 1200 Sixth St, Ste 400, Traverse City, MI 49684-2369 Ph: (231) 392-0655 | Debra Joan Kurtz, MD 1200 Sixth St, Ste 400, Traverse City, MI 49684-2369 Ph: (231) 392-0655 |
News Archive
A memorandum which is to lead to the re-training of five million village doctors in rural China is to be signed on 23 May in Beijing, China. The memorandum goes back to the initiative of Terence Ryan, Professor of Dermatology at the University of Oxford, who has been instrumental in drawing it up and will participate in the signing.
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
Advanced Biological Laboratories (ABL) is pleased to announce its recent signature of a non-exclusive international distribution agreement (excluding United States, Australia, Canada and United Kingdom) of virco®TYPE HIV-1, Belgium-based Virco BVBA's HIV resistance interpretation system.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended March 31, 2010 - the third quarter of the Company's 2010 fiscal year (3QFY10).
Today's headlines include continuing coverage about the problems with the healthcare.gov website, how Health and Human Services Secretary Kathleen Sebelius is in the hot seat and how the White House has called in reinforcements - a glitch czar.
› Verified 9 days ago
Diana Lynn Novak, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3960 W Royal Dr, Traverse City, MI 49684 Phone: 231-947-0404 Fax: 231-947-2190 | |
Dr. Laura J Danz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Jennie Rose, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4400 Lands End, Traverse City, MI 49686 Phone: 231-944-4171 | |
Dr. Don A Good, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Douglas L Mckay, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Marcy Verplanck-kanitz, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 |